Value of magnetocardiographic QRST integral maps in the identification of patients at risk of ventricular arrhythmias

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 9, 1999, Pages 1292-1304

  Hren, Rok ^b,c   Steinhoff, Uwe ^d   Gessner, Christof ^d   Endt, Peter ^d   Goedde, Peter ^a   Agrawal, Rahul ^a   Oeff, Michael ^a   Lux, Robert L ^c   Trahms, Lutz ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b INSTITUTE OF MATHEMATICS   (Slovenia)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

Magnetic field mapping; Magnetocardiography; QRST integral maps; Ventricular arrhythmia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; COVARIANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; MAGNETIC FIELD; MAGNETOCARDIOGRAPHY; MALE; QRS COMPLEX; SINUS RHYTHM; ST SEGMENT;

ADULT; AGED; BODY SURFACE POTENTIAL MAPPING; CARDIAC PACING, ARTIFICIAL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MAGNETICS; MALE; MIDDLE AGED; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0001745619     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00622.x     Document Type: Article

References (54)

1. 1. Myerburg RJ, Kessler KM, Kimura S, et al. Sudden cardiac death: Future approaches based on identification and control of transient risk factors. J Cardiovasc Electrophysiol 1992; 3:626-640.
2. 2. Cupples LA, Gagnon DR, Kannel WB. Long-and short-term risk of sudden cardiac death. Circulation 1992; 85(Suppl. I):I-11-1-18.
3. 3. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991; 18:687-697.
4. 4. SippensGroenewegen A, Spekhorst H, van Hemel NH, et al. Localization of the site of origin of postinfarction ventricular tachycardia by endocardial pace mapping: Body surface mapping compared with the 12-lead electrocardiogram. Circulation 1993; 88:2290-2306.
5. 5. Dubuc M, Nadeau R, Tremblay G, et al. Pace mapping using body surface potential maps to guide catheter ablation of accessory pathways in patients with Wolff-Parkinson-White syndrome. Circulation 1993; 87:135-143.
6. 6. Green LS, Lux RL, Ershler PR, et al. Resolution of pace mapping stimulus site separation using body surface potentials. Circulation 1994; 90:462-468.
7. 7. Hren R, Stroink G, Horà cek BM. Spatial resolution of body surface potential maps and magnetic field maps: A simulation study applied to the identification of ventricular preexcitation sites. Med Biol Eng Comput 1998; 36:145-157.
8. 8. SippensGroenewegen A, Spekhorst H, van Hemel NM, et al. Body surface mapping of ectopic left and right ventricular activation: QRS spectrum in patients without structural heart disease. Circulation 1990; 82:879-896.
9. 9. Abildskov JA, Green LS, Lux RL. Detection of disparate ventricular repolarization by means of the body surface electrocardiogram. In DP Zipes, J Jalife (eds.): Cardiac Electrophysiology and Arrhythmias. New York, NY, Grune & Stratton, 1985, pp. 495-499.
10. 10. Lux RL. Electrocardiographic mapping: Noninvasive electrophysiological cardiac imaging. Circulation 1993; 87:1040-1042.
11. 11. Taccardi B, Punske BB, Lux RL, et al. Useful lessons from body surface mapping. J Cardiovasc Electrophysiol 1998; 9:773-786.
12. 12. Abildskov JA, Burgess MJ, Ershler I, et al. Electrocardiographic recognition of states at high risk of ventricular arrhythmias. Circulation 1978; 58(Suppl. II):II-153.
13. 13. Abildskov JA, Green LS. The recognition of arrhythmia vulnerability by body surface electrocardiographic mapping. Circulation 1987; 75(Suppl. III):III-79-III-83.
14. 14. Yasamura S, Kubota I, Ikeda K, et al. Using body surface mapping to detect vulnerability to ventricular arrhythmias in patients with coronary heart disease. J Electrocardiol 1987; 20:114-120.
15. 15. Horà ek BM, Montague TJ, Gardner MJ, et al. Arrhythmogenic conditions. In DM Mirvis, (ed.): Body Surface Electrocardiographic Mapping. Boston, MA, Kluwer Academic Publishers, 1988, pp. 167-189.
16. 16. Gardner MJ, Montague TJ, Armstrong CS, et al. Vulnerability to ventricular arrhythmia: Assessment by mapping of body surface potential. Circulation 1986; 73:684-692.
17. 17. Hubley-Kozey CL, Mitchell LB, Gardner MJ, et al. Spatial features in body-surface potential maps can identify patients with a history of sustained ventricular tachycardia. Circulation 1995; 92: 1825-1838.
18. 18. Dambrink JE, SippensGroenewegen A, van Gilst WH, et al., for the Captopril and Thrombolysis Study Investigators. Association of left ventricular remodeling and nonuniform electrical recovery expressed by nondipolar QRST integral map patterns in survivors of a first anterior myocardial infarction. Circulation 1995; 92:300-310.
19. 19. Lant J, Stroink G, ten Voorde B, et al. Complementary nature of electrocardiographic and magnetocardiographic data in patients with ischemic heart disease. J Electrocardiol 1990; 25:315-322.
20. 20. Stroink G, Lamothe R, Gardner MJ. Magnetocardiographic and electrocardiographic mapping studies. In H Weinstock (ed.): SQUID Sensors: Fundamentals, Fabrication and Applications. Amsterdam, Kluwer, 1995, pp. 413-444.
21. 21. Brockmeier K, Schmitz L, Chavez JJB, et al. Magnetocardiography and 32-lead potentials: Repolarization in normal subjects during pharmacologically induced stress. J Cardiovasc Electrophysiol, 1997; 8:615-626.
22. 22. Weismüller P, Abraham-Fuchs K, Schneider S, et al. Magnetocardiographic non-invasive localization of accessory pathways in the Wolff-Parkinson-White syndrome by a multichannel system. Eur Heart J 1992; 13:616-622.
23. 23. Mäkijärvi M, Nenonen J, Leiniö M, et al. Localization of accessory pathways in Wolff-Parkinson-White syndrome by high resolution magnetocardiographic mapping. J Electrocardiol 1992; 25:143-155.
24. 24. Oeff M. Magnetocardiographic mapping. In M Shenasa, M Borggrefe, G Breithardt (eds.): Cardiac Mapping. Armonk NY, Futura Publishing Co., 1993, pp. 383-388.
25. 25. Weismüller P, Richter R, Abraham-Fuchs K, et al. Spatial differences of the duration of ventricular late fields in the signal-averaged magnetocardiograms in patients with ventricular late potentials. PACE 1993; 16:70-79.
26. 26. van Leeuwen P, Hailer B, Wehr M. Spatial distribution of QT intervals: An alternative approach to QT dispersion. PACE 1996; 19:1894-1899.
27. 27. Montonen J, Korhonen P, Mäkijärvi M, Spatial aspects in magnetocardiographic time domain and spoctrotemporal post-infarction arrhythmia risk assessment. In C Aine, YC Okada, G Stroink, et al. (eds.): Advances in Biomagnetism Research: Biomag '96. New York, NY, Springer-Verlag, 1998 (in press).
28. 28. Wilson FN, Macleod AG, Barker PS, et al. The determination and the significance of the areas of the ventricular deflections of the electrocardiogram. Am Heart J 1934; 10:46-61.
29. 29. Plonsey R. A contemporary view of the ventricular gradient of Wilson. J Electrocardiol 1979; 12: 337-341.
30. 30. Geselowitz DB. The ventricular gradient revisited: Relation to the area under the action potential. IEEE Trans Biomed Eng 1983; BME-30:76-77.
31. 31. Abildskov JA, Evans AK, Lux RL, et al. Direct evidence relating QRST deflection area and ventricular recovery properties. Circulation 1979; 60: 100-110.
32. 32. Abildskov JA. Effects of activation sequence on the local recovery of ventricular excitability in the dog. Circ Res 1976; 38:240-243.
33. 33. Lux RL, Urie PM, Burgess MJ, et al. Variability of the body surface distributions of QRS, ST-T, and QRST deflection areas with varied activation sequence in dogs. Cardiovasc Res 1980; 14:607-612.
34. 34. De Ambroggi L, Bertoni T, Locati E, et al. Mapping of body surface potentials in patients with the idiopathic long QT syndrome. Circulation 1986; 74:1334-1345.
35. 35. Tsunakawa H, Nishiyama G, Kusahana Y, et al. Identification of susceptibility to ventricular tachycardia after myocardial infarction by nondipolarity of QRST area maps. J Am Coll Cardiol 1989; 14:1530-1536.
36. 36. Wikswo JP Jr, Barach JP. Possible sources of new information in the magnetocardiogram. J Theor Biol 1982; 95:721-729.
37. 37. Stroink G, Laut J, Elliott P, et al. Discrimination between myocardial infarct and ventricular tachycardia patients using magnetocardiographic trajectory plots and iso-integral maps. J Electrocardiol 1992; 25:129-142.
38. 38. Drung D. The PTB 83-SQUID system for biomagnetic applications in a clinic. IEEE Trans Appl Supercon 1095; 5:2112-2117.
39. 39. Gerbrands JJ. On the relationship between SVD, KLT and PCA. Pattern Recognition 1981; 14: 375-381.
40. 40. Lux RL. Karhunen-Loeve representation of ECG data. J Electrocardiol 1992; 25(Suppl.):195-198.
41. 41. Lux RL, Smith CR, Wyatt RF, et al. Limited lead selection for estimation of body surface potential maps in electrocardiography. IEEK Trans Biomed Eng 1978; BME-25:270-276.
42. 42. Lux RL, Evans AK, Burgess MJ, et al. Redundancy reduction for improved display and analysis of body surface potential maps. I. Spatial compression. Circ Res 1981; 49:186-196.
43. 43. Abildskov JA, Urie PM, Lux RL, et al. Body surface distribution of QRST area. Adv Cardiol 1978; 21; 59-64.
44. 44. Montague TJ, Smith ER, Cameron DA, et al. Isointegral analysis of body surface maps: Surface distribution and temporal variabilitv in normal subjects. Circulation 1981; 63:1166-1172.
45. 45. De Ambroggi L, Aimé E, Ceriotti C, et al. Mapping of ventricular repolarization potentials in patients with arrhythmogenic right ventricular dysplasia: Principal component analysis of the ST-T waves, Circulation 1997; 96:4314-4318.
46. 46. Mitchell LB, Hubley-Kozey CL, Smith ER, et al. Electrocardiographic body surface mapping in patients with ventricular tachycardia: Assessment of utility in the identification of effective pharmacological therapy. Circulation 1992; 86:383-393.
47. 47. Peeters HAP, SippensGroenewegen A, Schoonderwoerd BA, et al. Body-surface QRST integral mapping: Arrhythmogenic right ventricular dysplasia versus idiopathic right ventricular tachycardia. Circulation 1997; 95:2668-2676.
48. 48. Platia EV, Reid PR. Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation. J Am Coll Cardiol 1984; 4:493-500.
49. 49. Kubota I, Lux RL, Burgess MJ, et al. Relation of cardiac surface QRST distributions to ventricular fibrillation threshold in dogs. Circulation 1988; 78:171-177.
50. 50. Burgess MJ. Ventricular repolarization and electrocardiographic T wave form and arrhythmia vulnerability. In MN Levy, M Vassalle (eds.): Excitation and Neural Control of the Heart. Bethesda, MD, American Physiological Society, 1982, pp. 181-202.
51. 51. Abildskov JA, Burgess MJ, Urie P, et al. The unidentified information content of the electrocardiogram. Circ Res 1977; 40:3-7.
52. 52. Roth BJ, Guo W, Wikswo JP Jr. The effect of spiral anisotropy on the electrical potential and the magnetic field at the apex of the heart. Math Biosci 1988; 88:191-221.
53. 53. Nenonen J, Horà ek BM. Extracardiac field due to propagated excitation in the ventricular myocardium. In DN Ghista (ed.): Vieweg, Wiesbaden, Biomedical and Life Physics, 1996, pp. 191-201.
54. 54. Smith JR, Gallen C, Orison W, et al. Role of multichannel magnetooncephalography in the evaluation of ablative seizure surgery candidates. Stereotact Funct Neurosurg 1994; 62:238-244.